Programs and studies

Clinical study

ACTIVE2

Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

StatusWithdrawn
TypeTrial
CountriesUnited States
Conditions studiedProsthetic Joint Infection
Study years2023–2027 (estimated)
Entry review2026-10-03

Participation

Check the study record or contact the study team for current recruitment and eligibility.

Study eligibility

Inclusion Criteria: * Males or females ≥18 years of age * Recurrent PJI of the knee or hip * Female patients of childbearing potential who agree to use contraception. * Confirmed phage match * No anticipated need for long-term antibiotics Exclusion Criteria: * Soft tissue defect requiring reconstruction * Hardware misalignment * Additional orthopedic hardware in connection with the infected prosthesis * Active infection (other than PJI) requiring long term IV antibiotics * Unable to tolerate SAT * Septic shock or hemodynamic instability * Stage 4 or greater chronic kidney disease * Liver disease * Decompensated heart failure * Positive drug screen * Receiving chemotherapy * Immunocompromised * Treatment with antiviral medication within 2 weeks prior to randomization * Currently participating in another clinical trial * Known phage allergy * Pregnant/ breast feeding * Lack of capacity to consent

Study description

This is a study designed to evaluate bacteriophage therapy in patients with chronic prosthetic joint infections.

Study registrations

ClinicalTrials.govNCT05269134
Recorded study locations (10)

Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.

University of California San Diego Medical Center

San Diego, California, United States

Recorded site status: Not separately listed. Study location source ↗

Hartford Health Care Bone & Joint Insitute

Hartford, Connecticut, United States

Recorded site status: Not separately listed. Study location source ↗

Snake River Research

Idaho Falls, Idaho, United States

Recorded site status: Not separately listed. Study location source ↗

University of Maryland Medical Center

Baltimore, Maryland, United States

Recorded site status: Not separately listed. Study location source ↗

Sinai Hospital of Baltimore

Baltimore, Maryland, United States

Recorded site status: Not separately listed. Study location source ↗

Brigham & Women's Hospital

Boston, Massachusetts, United States

Recorded site status: Not separately listed. Study location source ↗

New England Baptist Hospital

Boston, Massachusetts, United States

Recorded site status: Not separately listed. Study location source ↗

William Beaumont Hospital

Royal Oak, Michigan, United States

Recorded site status: Not separately listed. Study location source ↗

Mayo Clinic

Rochester, Minnesota, United States

Recorded site status: Not separately listed. Study location source ↗

WVU Medicine JW Ruby Memorial Hospital

Morgantown, West Virginia, United States

Recorded site status: Not separately listed. Study location source ↗

Related programs(2)

Sources and updates

Entry reviewed . This is the date of our source review, not a confirmation of availability today.

AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.

Study ID
nct05269134